Dr. Mina is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Dept. Of Pathology
Boston, MA 02115Phone+1 617-732-8613
Education & Training
Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2016 - 2020
Emory University School of MedicineClass of 2016
Princeton UniversityPost-Doctoral Fellowship, 2014 - 2015- Emory UniversityPh.D, Infectious Disease Immunology & Mathematics, 2007 - 2014
- Dartmouth CollegeA.B., Senior Fellowship, 2002 - 2006
Certifications & Licensure
MA State Medical License 2016 - 2021
Publications & Presentations
PubMed
- Evaluating COVID-19 Vaccines in the Era of Endemicity-Recency vs Reformulation.Gopi S Mohan, Michael J Mina, Pierre O Ankomah
JAMA Internal Medicine. 2024-08-01 - 8 citationsSerologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis.Marianna Cortese, Yumei Leng, Kjetil Bjornevik, Moriah Mitchell, Brian C Healy
JAMA Neurology. 2024-05-01 - 6 citationsAssessing the Effects of Measles Virus Infections on Childhood Infectious Disease Mortality in Brazil.Siyang Xia, Cricket C Gullickson, C Jessica E Metcalf, Bryan T Grenfell, Michael J Mina
The Journal of Infectious Diseases. 2022-12-28
Journal Articles
- Test Sensitivity Is Secondary to Frequency and Turnaround Time for COVID-19 SurveillanceMichael Mina, MD, medRxiv
Authored Content
- Test Sensitivity Is Secondary to Frequency and Turnaround Time for COVID-19 SurveillanceJune 2020
- Test Sensitivity Is Secondary to Frequency and Turnaround Time for COVID-19 SurveillanceJune 2020
Press Mentions
5 Ways RFK Jr. Could Undermine Lifesaving Childhood VaccinesNovember 19th, 2024- 40 Facts You NEED to Know: The REAL Story of “Covid” / by Kit KnightlyMarch 26th, 2023
- “COVID Rebound” Is Common – Even in Patients Not Treated with PaxlovidMarch 13th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
